OTETREVI Trademark

Trademark Overview

On Wednesday, October 2, 2019, a trademark application was filed for OTETREVI with the United States Patent and Trademark Office. The USPTO has given the OTETREVI trademark a serial number of 88639665. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 7, 2022. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The OTETREVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio-metabolic diseases and disorders
otetrevi

General Information

Serial Number88639665
Word MarkOTETREVI
Filing DateWednesday, October 2, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio-metabolic diseases and disorders
Translation of Words in MarkThe wording "OTETREVI" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, November 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 27, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 27, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 27, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022SOU EXTENSION 4 GRANTED
Monday, March 21, 2022SOU EXTENSION 4 FILED
Monday, March 21, 2022TEAS EXTENSION RECEIVED
Friday, September 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 22, 2021SOU EXTENSION 3 GRANTED
Wednesday, September 22, 2021SOU EXTENSION 3 FILED
Wednesday, September 22, 2021TEAS EXTENSION RECEIVED
Friday, April 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 7, 2021SOU EXTENSION 2 GRANTED
Wednesday, April 7, 2021SOU EXTENSION 2 FILED
Wednesday, April 7, 2021TEAS EXTENSION RECEIVED
Thursday, September 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 22, 2020SOU EXTENSION 1 GRANTED
Tuesday, September 22, 2020SOU EXTENSION 1 FILED
Tuesday, September 22, 2020TEAS EXTENSION RECEIVED
Sunday, June 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, June 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 6, 2020ASSIGNED TO EXAMINER
Sunday, October 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 5, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

otetrevi genetic infectious cardio metabolic disorders diseases hepatic ocular treatment preparations